Smit Hendrik J, Gaffan Elizabeth A, Rogers Peter J
Department of Experimental Psychology, University of Bristol, 8 Woodland Road, Bristol, BS8 1TN, UK.
Psychopharmacology (Berl). 2004 Nov;176(3-4):412-9. doi: 10.1007/s00213-004-1898-3. Epub 2004 May 5.
Liking, cravings and addiction for chocolate ("chocoholism") are often explained through the presence of pharmacologically active compounds. However, mere "presence" does not guarantee psycho-activity.
Two double-blind, placebo-controlled studies measured the effects on cognitive performance and mood of the amounts of cocoa powder and methylxanthines found in a 50 g bar of dark chocolate.
In study 1, participants ( n=20) completed a test battery once before and twice after treatment administration. Treatments included 11.6 g cocoa powder and a caffeine and theobromine combination (19 and 250 mg, respectively). Study 2 ( n=22) comprised three post-treatment test batteries and investigated the effects of "milk" and "dark" chocolate levels of these methylxanthines. The test battery consisted of a long duration simple reaction time task, a rapid visual information processing task, and a mood questionnaire.
Identical improvements on the mood construct "energetic arousal" and cognitive function were found for cocoa powder and the caffeine+theobromine combination versus placebo. In chocolate, both "milk chocolate" and "dark chocolate" methylxanthine doses improved cognitive function compared with "white chocolate". The effects of white chocolate did not differ significantly from those of water.
A normal portion of chocolate exhibits psychopharmacological activity. The identical profile of effects exerted by cocoa powder and its methylxanthine constituents shows this activity to be confined to the combination of caffeine and theobromine. Methylxanthines may contribute to the popularity of chocolate; however, other attributes are probably much more important in determining chocolate's special appeal and in explaining related self-reports of chocolate cravings and "chocoholism".
对巧克力的喜爱、渴望及成瘾(“巧克力成瘾症”)常通过药理活性化合物的存在来解释。然而,仅仅“存在”并不能保证其具有心理活性。
两项双盲、安慰剂对照研究测量了50克黑巧克力中可可粉和甲基黄嘌呤的含量对认知表现和情绪的影响。
在研究1中,参与者(n = 20)在接受治疗前完成一次测试组,治疗后完成两次测试组。治疗包括11.6克可可粉以及咖啡因和可可碱的组合(分别为19毫克和250毫克)。研究2(n = 22)包括三个治疗后测试组,并研究了这些甲基黄嘌呤的“牛奶巧克力”和“黑巧克力”含量的影响。测试组包括一个长时间简单反应时间任务、一个快速视觉信息处理任务和一份情绪问卷。
可可粉以及咖啡因与可可碱的组合与安慰剂相比,在情绪结构“精力充沛的兴奋感”和认知功能方面有相同程度的改善。在巧克力中,与“白巧克力”相比,“牛奶巧克力”和“黑巧克力”中的甲基黄嘌呤剂量均改善了认知功能。白巧克力的效果与水的效果没有显著差异。
正常份量的巧克力具有精神药理活性。可可粉及其甲基黄嘌呤成分所产生的相同效果表明,这种活性仅限于咖啡因和可可碱的组合。甲基黄嘌呤可能有助于巧克力的普及;然而,在决定巧克力的特殊吸引力以及解释与巧克力渴望和“巧克力成瘾症”相关的自我报告方面,其他属性可能更为重要。